1. Introduction {#sec1-cancers-12-00387}
===============

The intracellular pH (pH~i~) in most mature mammalian cells is kept within a narrow range (≈7.2) through the combined operation of the active transmembrane transporters and the passive intracellular buffering capacity (β) \[[@B1-cancers-12-00387]\]. Homeostasis of pH~i~ regulates many cellular functions, such as cell growth, migration, and apoptosis in mammalian cells. However, some cancer cells have been found recently with alkaline pH~i~ values (≥7.2) and acidic pH~e~ values (≤7.0) \[[@B2-cancers-12-00387],[@B3-cancers-12-00387],[@B4-cancers-12-00387]\]. This "reversed" gradient enables cancer progression by promoting proliferation, evasion of apoptosis, migration, and invasion \[[@B5-cancers-12-00387],[@B6-cancers-12-00387]\]. Indeed, during the development of tumors, cancer cells have developed a special cellular energetic and metabolic way that affects the homeostasis of extracellular pH (pH~e~) and pH~i~. In the absence or presence of oxygen, pyruvate is mostly converted to lactate via glycolysis in cancer cells, a process known as the Warburg effect or aerobic glycolysis, which is less efficient than oxidative phosphorylation for generating ATP (2 and 36 ATP, respectively). Thus, cancer cells increase their glucose uptake and glycolytic rate to produce more ATP. However, the accumulation of glycolytic byproducts, like lactate and H^+^, can lead to the intra- and extracellular acidification \[[@B7-cancers-12-00387]\]. Maintenance of stable, mildly alkaline pH~i~ by activating some acid extruding mechanisms is required for cancer cell proliferation and differentiation \[[@B5-cancers-12-00387],[@B6-cancers-12-00387]\]. Furthermore, it has been shown that growth factor signaling is associated with pH~i~ increase leading to cell stimulation and proliferation. In contrast, a decrease in pH~i~ can result in cellular apoptosis. Moreover, mitochondria-induced acidification of the cytosol has been found as an early event that regulates Caspase activation in the mitochondrial pathway \[[@B8-cancers-12-00387]\]. Therefore, the pH~i~ homeostasis is vital for the cancer development and progression.

Several different transmembrane pH~i~ regulators can be allocated into two main groups: H^+^-equivalent extruders and H^+^-equivalent loaders. H^+^-equivalent extruders, such as Na^+^/H^+^ exchanger (NHE) \[[@B9-cancers-12-00387]\] and Na^+^/HCO~3~^−^ cotransporter (NBC), are activated when intracellular pH decreases (pH~i~ \< 7.1) \[[@B10-cancers-12-00387],[@B11-cancers-12-00387]\]. Likewise, when pH~i~ becomes alkaline (pH~i~ \> 7.4), the H^+^-equivalent loaders, such as Cl^−^/HCO~3~^−^ exchanger (AE) \[[@B11-cancers-12-00387]\] and Cl^−^/OH^−^ exchanger (CHE) \[[@B11-cancers-12-00387],[@B12-cancers-12-00387]\] will be activated. Moreover, a reversible lactic acid carrier, i.e., H^+^-Monocarboxylate^−^ cotransporters (MCT), and V-ATPase are highly activated during the development of tumors or under conditions of ischemia/hypoxia \[[@B12-cancers-12-00387],[@B13-cancers-12-00387]\]. In HEPES-buffered media (HCO~3~^−^-free condition), pH~i~ recovery following intracellular acidosis is inhibited by removal of extracellular Na^+^ or by adding Hoe 694 (3-methylsulfonyl-4-piperidinobenzoyl, guanidine hydrochloride), a high affinity and selectivity NHE-1 inhibitor \[[@B9-cancers-12-00387]\]. Moreover, NHE activation has been found to enhance tumor cell migration and invasion by creating a distinct cell surface pH gradient and invadopodial-dependent extracellular matrix degradation in human endometrial cancer cells, human breast carcinoma, and melanoma cells \[[@B4-cancers-12-00387],[@B14-cancers-12-00387],[@B15-cancers-12-00387],[@B16-cancers-12-00387],[@B17-cancers-12-00387]\]. The rise in pH~i~ through activation of the NHE that modulated by growth factors plays an important role in growth control in tumor tissues \[[@B18-cancers-12-00387],[@B19-cancers-12-00387]\]. Some of the Bcl-2 family proteins \[[@B20-cancers-12-00387]\] and endonucleases \[[@B21-cancers-12-00387]\] have been identified as pH sensitive during early intracellular alkalinization in apoptosis \[[@B22-cancers-12-00387]\]. Moreover, treatment with p90rsk inhibitor has been found to reduce the ethanol-induced increase in viability of cells and expression of Na^+^/H^+^ exchanger isoform 1 (NHE1) and Bcl-2 in hepatocellular carcinoma \[[@B23-cancers-12-00387]\]. However, the related knowledge of transmembrane pH~i~ regulators is still not clear in human normal endocervical cells (End1), human normal ectocervical cells (Ect1), and in human cervical cancer cells (HeLa).

In traditional herbal medicine, *Andrographis paniculata* (Burm. F), generally known as the "king of bitters", has attracted wide attention due to its multiple effects: anti-oxidative, anti-diabetic, hepatoprotective, and anti-inflammatory \[[@B24-cancers-12-00387],[@B25-cancers-12-00387],[@B26-cancers-12-00387]\]. Recently, studies suggested that *Andrographis paniculata* had anti-tumor and immunomodulatory effects in vitro and in vivo \[[@B27-cancers-12-00387],[@B28-cancers-12-00387],[@B29-cancers-12-00387]\]. For example, the aqueous extract of *Andrographis paniculata* exerted inhibitory activities on the migration of esophageal cancer cells, and suppressed the proliferation and motility of endothelial cells \[[@B28-cancers-12-00387]\]. Moreover, Andrographolide, the major labdane diterpenoid compound from *Andrographis paniculata* has been reported to be cytotoxic against various cancer cells in vitro, including human leukemic, lymphocytic cell lines, P-388, KB, COL-2, MCF-7, LU-1, and ASK cells \[[@B27-cancers-12-00387],[@B30-cancers-12-00387],[@B31-cancers-12-00387],[@B32-cancers-12-00387]\], mainly with the underlying mechanism of stimulating the production of cytotoxic T lymphocyte through enhanced secretion of IL-2, tumor necrosis factor-alpha secretion, and interferon-gamma \[[@B27-cancers-12-00387]\]. Andrographolide was also found to inhibit the proliferation of various cell lines including leukemia, breast cancer, lung cancer, and melanoma cells \[[@B33-cancers-12-00387],[@B34-cancers-12-00387]\]. On the other hand, in vivo models, Andrographolide was also found to show anti-cancer activity in B16F0 melanoma syngenic, MCF-7, and HT-29 xenograft models \[[@B33-cancers-12-00387],[@B35-cancers-12-00387]\]. Moreover, the compound exerted direct anticancer activity, both in vitro and in vivo experiments, on cancer cells by cell-cycle arrest at G0/G1 phase through induction of cell-cycle inhibitory protein p27 and decreased expression of cyclin-dependent kinase 4 (CDK4) \[[@B33-cancers-12-00387],[@B36-cancers-12-00387],[@B37-cancers-12-00387]\].

Apoptosis is a cell death process, and lack of apoptotic induction has been implicated in tumor development and progression \[[@B38-cancers-12-00387]\]. Among many apoptotic regulatory proteins, the Bcl-2 family, including both anti-apoptotic (Bcl-2, Bcl-XL, Mcl-1) and pro-apoptotic members (Bid, Bax, Bad), is particularly important \[[@B39-cancers-12-00387]\]. Moreover, studies with several different breast cancer cell lines indicated that the relative amounts of Bcl-2 and Bax proteins are highly predictive of the sensitivity to apoptosis, with the increase of Bax/Bcl-2 ratio, in mammary tumor cells \[[@B40-cancers-12-00387]\]. A potent growth inhibitory effect of Andrographolide, after a 48-h treatment, was demonstrated in acute promyelocytic leukemia cells (HL-60 and NB4) by inducing cell differentiation and apoptosis \[[@B41-cancers-12-00387],[@B42-cancers-12-00387]\]. The 50% cell growth inhibition concentration of Andrographolide ranges from 10 to 100 μM, depending on the type of cancer cell tested \[[@B29-cancers-12-00387]\]. For example, some reports showed that Andrographolide at relatively high concentrations (from 40 to 100 μM) could induce apoptosis in human prostatic adenocarcinoma PC-3 cells \[[@B43-cancers-12-00387]\] or human leukemic HL-60 cells \[[@B44-cancers-12-00387]\]. However, there are no previous reports on Andrographolide on pH~i~ regulators, cellular migration, and apoptosis in human cervical cancer cells. In light of the importance of pH~i~ homeostasis on cancer progress, the aim of the present study was to characterize the functional acid extruding mechanism and examine the effect of various concentrations of Andrographolide (3--1000 μM) on pH~i~ regulation, cellular migration, and apoptosis in cultured human cervical cancer cells.

2. Result {#sec2-cancers-12-00387}
=========

2.1. Resting and New Steady-State Intracellular pH Value of Cultured Cells of HeLa, End1, and Ect1 {#sec2dot1-cancers-12-00387}
--------------------------------------------------------------------------------------------------

To examine the resting pH~i~ of the cultured cells of End1, Ect1, and HeLa, the cells were superfused with HEPES-buffered solution (nominally free of CO~2~/HCO~3~^−^; pH~o~ 7.40). Under the HEPES-buffered solution, the original resting pH~i~ value was 7.31 ± 0.07 (*n* = 5), 7.30 ± 0.06 (*n* = 5), and 7.47 ± 0.04 (*n* = 20), in the End1 cells, Ect1 cells, and HeLa cells as shown in the farthest left part of [Figure 1](#cancers-12-00387-f001){ref-type="fig"}A--C, respectively. The steady-state pH~i~ value was shifted from alkaline to the new acidic steady-state value of pH~i~ in all three tested cells, i.e., the End1 cells, Ect1 cells, and HeLa cells. The new steady-state value of pH~i~ was 7.21 ± 0.07 (*n* = 5; *p* \< 0.05), 7.19 ± 0.06 (*n* = 5; *p* \< 0.05), and 7.25 ± 0.04 (*n* = 20; *p* \< 0.001) after intracellular acid/base impact by applying NH~4~Cl (20 mM) prepulse for three times in the End1 cells, Ect1 cells, and HeLa cells as shown in most right part of [Figure 1](#cancers-12-00387-f001){ref-type="fig"}A--C, respectively. Note that the NH~4~Cl prepulse method can be explained by four phases as shown in the farthest left part of [Figure 1](#cancers-12-00387-f001){ref-type="fig"}C: phase 1 (rapid alkalization), phase 2 (slow recovery), phase 3 (rapid acidification), and phase 4 (pH~i~ regulation), and see more details in [Section 4](#sec4-cancers-12-00387){ref-type="sec"}. As shown in the farthest left part of [Figure 1](#cancers-12-00387-f001){ref-type="fig"}A--C, the pH~i~ recovered completely from intracellular acidosis that was induced by using an NH~4~Cl prepulse technique. This result indicated that there is a mechanism of acid extrusion in the End1 cells, Ect1 cells, and HeLa cells, respectively. Note that the slope value of the pH~i~ recovery (dpH~i~/min) in the three cell lines (End 1, Ect1, and Hela) was 0.12 ± 0.02 (*n* = 5); 0.11 ± 0.01 (*n* = 5); 0.07 ± 0.02 (*n* = 20), respectively (measured for pH~i~ range of = 6.95 ± 0.02),

2.2. Functional Identification of Intracellular Acid Extruders---NHE and V-ATPase {#sec2dot2-cancers-12-00387}
---------------------------------------------------------------------------------

To examine whether the active transmembrane acid extrusion mechanism in the three different tested cell cultures, i.e., the End1 cells, Ect1 cells, and HeLa cells, is Na^+^-dependent, the cells were further performed in Na^+^-free HEPES-buffered superfusate. As shown in the farthest left part of [Figure 2](#cancers-12-00387-f002){ref-type="fig"}A--C, the pH~i~ recovered completely from intracellular acidosis as control in normal HEPES-buffered system. The removal of the extracellular Na^+^ totally inhibited the pH~i~ recovery rate in End1 cells and Ect1 cells, as shown in the right part of [Figure 2](#cancers-12-00387-f002){ref-type="fig"}A,B, respectively. This clearly demonstrates that, under nominally CO~2~/HCO~3~^−^-free conditions, the CO~2~/HCO~3~^−^-independent acid-extrusion mechanism that was involved in the pH~i~ recovery following induced intracellular acidification is purely Na^+^-dependent. On the other hand, the pH~i~ recovery after NH~4~Cl-induced intracellular acidification was only significantly slowed (−65%) but not completely blocked by perfusion with Na^+^ free solution in HEPES-buffered system in HeLa cells, as shown in the right part of [Figure 2](#cancers-12-00387-f002){ref-type="fig"}C. This demonstrated that besides Na^+^-dependent acid-extruder(s), there is another Na^+^-independent extrusion mechanism (≈35%) responsible for the remaining acid extrusion in HEPES solution in HeLa cells. Histograms of [Figure 2](#cancers-12-00387-f002){ref-type="fig"}D--F show the pH~i~ recovery slope (%) following induced intracellular acidification averaged for six experiments were similar to those shown in [Figure 2](#cancers-12-00387-f002){ref-type="fig"}A--C, respectively.

To further test if the Na^+^-dependent acid extruder is the NHE1 in the human normal cervical cells, i.e., End1 cells and Ect1 cells, as shown in the [Figure 2](#cancers-12-00387-f002){ref-type="fig"}A,B, respectively, we added HOE 694, a specific NHE1 inhibitor, in the superfusate. As shown in the right part of [Figure 3](#cancers-12-00387-f003){ref-type="fig"}A,B, HOE 694 ((3-methylsulphonyl-4- piperidino-benzoyl) guanidine methanesulphonate) (50 µM) entirely inhibited the pH~i~ recovery following the induced intracellular acidification in the End1 cells and Ect1 cells, respectively. On the other hand, the similar protocol of adding HOE 694 only partially inhibited pH~i~ recovery rate (≈60%) in the human cervical cancer cells, i.e., HeLa cells, as shown in [Figure 3](#cancers-12-00387-f003){ref-type="fig"}C. Therefore, the present results provide clear pharmacological evidence that NHE1 exists functionally in the End1 cells, Ect1 cells, and HeLa cells. Moreover, these results indicate that another acid-extruding mechanism apart from NHE1 exists in HeLa cells. The histograms in [Figure 3](#cancers-12-00387-f003){ref-type="fig"}E--G show the mean pH~i~ recovery slope before and after HOE 694 addition for several experiments that are similar to those whose results are shown in [Figure 3](#cancers-12-00387-f003){ref-type="fig"}A--C, respectively. Note that a further acidification was observed after the removal of Na from the superfusate while the addition of cariporide (HOE 694) did not cause further acidification. The possible underling mechanism for such difference has been illustrated in the [Section 3](#sec3-cancers-12-00387){ref-type="sec"}.

To further investigate whether the remaining Na^+^-independent pH~i~ recovery, i.e., could not be inhibited by Na^+^-free solution ([Figure 2](#cancers-12-00387-f002){ref-type="fig"}C) and HOE 694 ([Figure 3](#cancers-12-00387-f003){ref-type="fig"}C), is caused by the vacuolar-type ATPase (V-ATPase) in the HeLa cells, the HeLa cells were perfused with an HOE 694/Na^+^-free solution pulse with 30 μM bafilomycin A1 (Balifo; V-ATPase-specific inhibitor), as shown in the farthest right part of [Figure 3](#cancers-12-00387-f003){ref-type="fig"}C,D. Either adding HOE 694 pulse bafilomycin-A1 or removing Na^+^ pulse adding bafilomycin-A1 totally blocked the pH~i~ recovery, as shown in the middle part and right part of [Figure 3](#cancers-12-00387-f003){ref-type="fig"}E, respectively. These results provided functional evidence that V-ATPase plays a role of ≈40% in acid extrusion in HeLa cells. The histograms of [Figure 3](#cancers-12-00387-f003){ref-type="fig"}F,G show the mean pH~i~ recovery slope for six experiments that are similar to what are shown in [Figure 3](#cancers-12-00387-f003){ref-type="fig"}C,D, respectively.

2.3. The Effect of Andrographolide on the Functional Activity of NHE and V-ATPase in HeLa Cells {#sec2dot3-cancers-12-00387}
-----------------------------------------------------------------------------------------------

To measure the effect of Andrographolide on the functional activity of NHE1 and V-ATPase, the HeLa cells were superfused with various concentrations of Andrographolide (10--1000 µM) during the pH~i~ recovery that followed NH~4~Cl-induced intracellular acidification in HEPES-buffered solution ([Figure 4](#cancers-12-00387-f004){ref-type="fig"}A). As shown in [Figure 4](#cancers-12-00387-f004){ref-type="fig"}A, a lower concentration of Andrographolide (10 µM) did not change pH~i~ recovery in HEPES-buffered solution. However, acute addition of higher concentrations of Andrographolide (≥30 µM) inhibited the pH~i~ recovery in a concentration-dependent way, as shown in the right parts of [Figure 4](#cancers-12-00387-f004){ref-type="fig"}A. Note that the inhibition of NHE1 activity by 1000 µM of Andrographolide was dramatic (\>−80%). However, the reversible recovery to normal implies that the inhibitory effect on pH~i~ recovery was from Andrographolide, instead of the deteriorated condition of cell itself. The histogram in [Figure 4](#cancers-12-00387-f004){ref-type="fig"}B shows the normalization of pH~i~ recovery rate of acid extrusion averaged for nine experiments similar to that shown in [Figure 4](#cancers-12-00387-f004){ref-type="fig"}A. Moreover, as repetition of NH~4~Cl prepulses might have an effect on the consecutive recovery rates, we executed an extra control experiment with six consecutive prepulses without addition of Andrographolide, as shown in [Figure 4](#cancers-12-00387-f004){ref-type="fig"}C. The result of [Figure 4](#cancers-12-00387-f004){ref-type="fig"}C showed that the repetition of six consecutive NH~4~Cl did not show a significant effect on the pHi recovery rates in HeLa cells. Therefore, our present results provided direct evidence that Andrographolide inhibited activity of NHE1/V-ATPase in a concentration-dependent way in HeLa cells.

2.4. The Effect of Pretreating with Various Concentration of Andrographolide for 24 and 48 h on Proliferation/Viability and Cell Migration {#sec2dot4-cancers-12-00387}
------------------------------------------------------------------------------------------------------------------------------------------

The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) assay is the gold standard for determination of the signal from living cells, rather than dead cells, by measuring reductive activity of dehydrogenase as enzymatic conversion of the tetrazolium compound to water insoluble formazan crystals \[[@B45-cancers-12-00387]\]. To check the chronic effect of Andrographolide on proliferation/viability in End1, Ect1, and HeLa cells, the various concentrations of Andrographolide (3--1000 μM) were added to the culture solution for 24--48 h incubation. The original images of cell morphology in our present study showed that Andrographolide concentration-dependently inhibited the viability of HeLa cells both for 24 and 48 h, as shown in [Figure 5](#cancers-12-00387-f005){ref-type="fig"}A,B, respectively. Moreover, the Andrographolide-induced inhibition on viability was significant from 30 and 10 μM for the groups of 24 and 48 h, respectively. Note that the higher concentrations of 300 and 1000 μM Andrographolide inhibited cell viability dramatically (\>90%). The statistical concentration dependent curves of Andrographolide on cell viability in [Figure 5](#cancers-12-00387-f005){ref-type="fig"}C,D show the mean percentage of cell viability for five experiments that are similar to those shown in [Figure 5](#cancers-12-00387-f005){ref-type="fig"}A,B (*n* = 5; *p* \< 0.005), respectively. Additionally, similar experiments were applied to End1 cells and Ect1 cells, and the statistical concentration dependent curves of Andrographolide on cell viability were shown as blue color and green color in [Figure 5](#cancers-12-00387-f005){ref-type="fig"}C,D, respectively. The result showed that Andrographolide did not affect the viability until the concentration was higher than 100 μM (48 h, *n* = 8, *p* \< 0.005) and 300 μM (24 h, *n* = 8, *p* \< 0.005) in End1 cells and Ect1 cells, respectively. The IC50 (half maximal inhibitory concentration) values of Andrographolide-induced inhibition on viability in HeLa cells, End1 cells, and Ect1 cells were 54.5, 303.8, and 200.7 μM, respectively, for 24 h. Moreover, the IC50 values of Andrographolide-induced inhibition on viability in HeLa cells, End1 cells, and Ect1 cells were 10.1, 157.6, and 157.6 μM, respectively, for 48 h.

In order to check whether Andrographolide shows an anti-cancer effect of migration, the wound-healing assay experiments (see [Section 4](#sec4-cancers-12-00387){ref-type="sec"} for details) were further executed in the human cervical cancer cells, i.e., HeLa cells. The differences in gap closure between before and after adding various concentrations of Andrographolide for 24 and 48 h, respectively, were measured. If there is a significant difference in gap closure, it represents the anti-migration ability of Andrographolide in human cervical cancer cells. As shown in [Figure 6](#cancers-12-00387-f006){ref-type="fig"}A, the fixed gap of monolayer cells was created by covering a fixed small box (upper row of [Figure 6](#cancers-12-00387-f006){ref-type="fig"}A; denoted as 0 h) and the migration into the gap was imaged at the time of 24 and 48 h (middle and lower row of [Figure 6](#cancers-12-00387-f006){ref-type="fig"}A, respectively) after adding Andrographolide in the HeLa cells for culture. As shown in [Figure 6](#cancers-12-00387-f006){ref-type="fig"}, Andrographolide (50--300 μM) significantly inhibited HeLa cell migration at 24 h (−26% to −84%, respectively) and 48 h (−34% to −95%, respectively). Note that the concentration of 300 μM Andrographolide not only totally inhibited migration, but also caused cell death, as shown in the farthest right pane of [Figure 6](#cancers-12-00387-f006){ref-type="fig"}A. Moreover, the enlarged pictures of the related higher concentrations are located at the right bottom of [Figure 6](#cancers-12-00387-f006){ref-type="fig"}A. The histogram of [Figure 6](#cancers-12-00387-f006){ref-type="fig"}B,C shows the normalization of migration inhibition percentage that was averaged for 11 experiments similar to those shown in [Figure 6](#cancers-12-00387-f006){ref-type="fig"}A.

2.5. The Effect of Pretreating with Various Concentration of Andrographolide for 24 and 48 h on Protein Expression of NHE1, Bcl-2, PARP, Cleaved PARP, Pro-Caspase 3, and Cleaved Caspase 3 {#sec2dot5-cancers-12-00387}
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Andrographolide inhibits cell viability in a concentration-dependent way in human cervical cancer cells, i.e., HeLa cells, whereas it does not in normal cervical cells, i.e., End1 and Ect1. Therefore, we wish to check whether the Andrographolide-induced viability inhibition was related to apoptosis. In order to check the impact of pretreating with various concentrations of various concentrations of Andrographolide for 24 and 48 h on the proteins expression of acid extruder NHE1 and apoptosis-related factors, such as Bcl-2, poly-ADP-ribose-polymerase (PARP), cleaved PARP, pro-Caspase 3, and cleaved Caspase 3 in culture HeLa cells, we used the Western blot technique in the further experiments as shown in [Figure 7](#cancers-12-00387-f007){ref-type="fig"}A. Our present study showed that the expression of NHE1, Bcl-2, PARP, cleaved PARP, pro-Caspase 3, and cleaved Caspase 3 was significantly reduced by treating with 100 µM Andrographolide for 24 and 48 h in HeLa cells (*n* = 4, \* *p* \< 0.05 or \*\* *p* \< 0.005), as shown in the histograms of [Figure 7](#cancers-12-00387-f007){ref-type="fig"}B--E, respectively. These results suggested that the inhibition of cell migration by Andrographolide was mainly due to the decreasing functional activity and/or downregulation of protein expression of NHE1, and that the activation of apoptotic pathway involved with Bcl-2, PARP, and Caspase 3 played a key role on the mechanism of Andrographolide-induced anti-cancer effect.

3. Discussion {#sec3-cancers-12-00387}
=============

3.1. The Resting pH~i~ and New Steady-State pH~i~ in Human Cervical Cancer Cells {#sec3dot1-cancers-12-00387}
--------------------------------------------------------------------------------

Cellular functions and activities are regulated by the delicate homeostasis of pH~i~. Recently, it has been demonstrated that a reversed transmembrane pH gradient is evolving as a hallmark of cancer tissues, i.e., high pH~i~ and low pH~o~ that enables cancer progression by promoting proliferation, the evasion of apoptosis, metabolic adaptation, migration, and invasion \[[@B5-cancers-12-00387]\]. In our present study, in the cultured human cervical cancer cells, we have found that the original resting pH~i~ value of HeLa cells is quite alkaline (7.47) under HEPES-buffered Tyrode solution (left part of the [Figure 1](#cancers-12-00387-f001){ref-type="fig"}C). On the other hand, the original resting pH~i~ of the human normal ectocervical cells (Ect1 cells; [Figure 1](#cancers-12-00387-f001){ref-type="fig"}B) and the human normal endocervical cells (End1 cells; [Figure 1](#cancers-12-00387-f001){ref-type="fig"}A) were significantly more acidic (7.31 and 7.30, respectively) than that in HeLa cells under HEPES-buffered Tyrode solution. Therefore, our present findings implicate that human cultured cervical cancer cells have the phenomenon of high pH~i~ similar like that of highly proliferated cells, i.e., embryonic stem cells and cancer cells (≈7.4) \[[@B5-cancers-12-00387],[@B46-cancers-12-00387],[@B47-cancers-12-00387]\]. However, the evidence derived from the present findings has to be cautioned for the following reasons. Firstly, the result of the present study was based on cancer cell lines. Secondly, it was based on CO~2~/HCO~3~^−^-buffer free conditions, where pH~i~ in Hela cells was significantly higher than in Ect1 and End1 cells, but it cannot be generalized for all cancer cell types/lines and for CO~2~/HCO~3~ containing physiological conditions \[[@B48-cancers-12-00387],[@B49-cancers-12-00387]\]. For example, the previous data of Swietach group showed that, in CO~2~/HCO~3~^−^-buffered condition, the steady state the pH~i~ of eight carcinoma cell lines of various origin (HCT116, RT112, MDA-MB-468, MCF10A, HT29, HT1080, MiaPaca2, and HeLa) were in range of 6.9--7.3, and 7.1 for HeLa cells \[[@B48-cancers-12-00387]\]. Steady-state pH~i~ is a balance through the combined operation of passive intracellular buffering power and active transmembrane pH~i~ transporters \[[@B50-cancers-12-00387],[@B51-cancers-12-00387],[@B52-cancers-12-00387]\]. Therefore, the functional characterization of acid extruders and acid loaders, and the change of their activity during the pathophysiological progress in HeLa cells await to be examined. Moreover, such alkaline pH~i~ value of HeLa cells was shifted to a new, steady-state pH~i~ value of 7.25 after a few intracellular acid/base impacts of NH~4~Cl prepulse, under HEPES-buffered Tyrode (the farthest right part of [Figure 1](#cancers-12-00387-f001){ref-type="fig"}C). Such new steady-state pH~i~ value is nearly the same as that of normal animal/human mature cells (≈7.2) \[[@B1-cancers-12-00387],[@B11-cancers-12-00387],[@B50-cancers-12-00387],[@B51-cancers-12-00387],[@B53-cancers-12-00387]\], as well as that that of HeLa cells (≈7.1) measured under CO~2~/HCO~3~ condition \[[@B48-cancers-12-00387]\]. Note that a similar result of shifting was also found in the human normal ectocervical cells, i.e., Ect1 cells ([Figure 1](#cancers-12-00387-f001){ref-type="fig"}B) and in the human normal endocervical cells, i.e., End1-cells ([Figure 1](#cancers-12-00387-f001){ref-type="fig"}A). Whether the acid/base impact-induced shift of ≈0.1 to ≈0.2 pH~i~ is simply a unique character of each cell type or complicatedly caused by changing pH~i~ regulating mechanism during the progress of cancer cells awaits further study. For example, a study showed that female vaginas provide a characteristic low-Na^+^ and low-pH fluid microenvironment (pH 3.6--4.4) that is considered generally protective \[[@B54-cancers-12-00387]\]. If the pH~e~ inside the vaginal tissue, which is dictated by blood perfusion, is higher and subsequently activates the NHE1 activity. Such interference on pH~i~/pH~e~ might cause an impact on the environment (\>4.7) and abnormal vaginal flora are correlated with human immunodeficiency virus and infertility \[[@B55-cancers-12-00387]\]. Therefore, the knowledge of special character of shifting pH~i~ from alkaline to acidic after intracellular acid/base impacts might provide another new insight on developing related medicines to cure human cervical cancer or carcinoma. Furthermore, in our present study, neither HEPES-buffered (carbonate buffer free) solution nor the large pH changes during the ammonium prepulse are physiological. The ammonium prepulse is a useful tool to trigger and measure the acid extrusion rate, but not very useful for assumptions about mechanisms used by cells to set new steady state pH~i~. In intact tissue (whether cancerous or healthy) the fluxes maintaining the steady state pH are low as compared to the new steady after an ammonium prepulse. In order to draw conclusions about steady state intracellular pH measurements in the presence of CO~2~/bicarbonate and absence of bicarbonate and with and without andrographolide would be necessary in the further experiments.

Note that in the results in [Figure 2](#cancers-12-00387-f002){ref-type="fig"}A, there was still a very visible acidification in Na-free superfusate in both Ect1 and End1. On the contrary, no further acidification was observed after adding cariporide (HOE 694) in both Ect1 and End1, as shown in [Figure 3](#cancers-12-00387-f003){ref-type="fig"}A,B. The reason behind this is mainly because that the removal of Na from superfusate could completely inhibit all Na-dependent acid extruding mechanism, including all isoforms of NHE, say NHE2--9, apart from the main acid extruding mechanism of NHE1. Therefore, after the complete inhibition of acid extruding mechanism, the acidic cellular metabolites were continuously accumulated inside the cells to cause further acidification in both Ect1 and End 1, as shown in [Figure 2](#cancers-12-00387-f002){ref-type="fig"}A. However, the cariporide (HOE 694) could only specifically inhibit the activity of NHE1 compared to that of other NHE isoforms. Therefore, the residue but minor acid extruding mechanism still worked, more or less. Therefore, although the pH~i~ recovery slope was completely inhibited, the accumulation of acid could be somehow extruded which prevents the further acidification in both Ect1 and End1, as shown in [Figure 3](#cancers-12-00387-f003){ref-type="fig"}A,B.

3.2. Potential Role of Inhibitors/Activators of Isoforms of NHE and V-ATPase in a Clinical Setting {#sec3dot2-cancers-12-00387}
--------------------------------------------------------------------------------------------------

In mammalian cells, in addition to the ubiquitous NHE1 acid extruder, the vacuolar-H^+^-ATPase (V-ATPase) utilizes the ATP to pump protons to the extracellular environment. V-ATPase has been reported as an important pH~i~ regulator in many different types of cancers and as being positively correlated to cancer invasion and metastasis \[[@B56-cancers-12-00387],[@B57-cancers-12-00387]\]. In our present study, we provide straightforward and convincing functional evidence that NHE1 and V-ATPase are functionally responsible for acid extrusion, following induced acidosis in HeLa cells, as shown in [Figure 3](#cancers-12-00387-f003){ref-type="fig"}C,D. On the other hand, the V-ATPase has not been found to play a functional role in the pH~i~ recovery following induced intracellular acidification both in human normal cervical cells, i.e., Ect1 cells and End1 cells ([Figure 2](#cancers-12-00387-f002){ref-type="fig"}A,B and [Figure 3](#cancers-12-00387-f003){ref-type="fig"}A,B). This is a very unique characteristic difference between the human cervical normal (End1 and ECT1) and cancer cells (HeLa), which can provide a clue for strategy of treating cervical cancer in clinics. Moreover, our present findings provide that the Andrographolide-induced inhibition on the activity of NHE1 and V-ATPase ([Figure 4](#cancers-12-00387-f004){ref-type="fig"}) might play an important role in Andrographolide-induced inhibition on cell migration/proliferation ([Figure 5](#cancers-12-00387-f005){ref-type="fig"} and [Figure 6](#cancers-12-00387-f006){ref-type="fig"}). In other words, our present study has suggested that specific inhibitors of NHE1/V-ATPase could be a promising pharmacological agent for human cervical cancer or carcinoma. Therefore, further studies on other active acid extruders and/or acid loaders of HeLa/cervical cancer tissues should be conducted in the physiological condition. Additionally, the effects of knock down or overexpression of specific pH~i~ regulators is worth observing in HeLa cells to see the role of pH~i~ regulators on the cellular development and progression of cancer disease.

3.3. The Acute and Chronic Effect of Andrographolide on Intracellular pH Regulating Mechanism and Apoptosis in Cervical Cancer Cells {#sec3dot3-cancers-12-00387}
------------------------------------------------------------------------------------------------------------------------------------

Our present study has, for the first time, provided straightforward evidence concerning acute ([Figure 4](#cancers-12-00387-f004){ref-type="fig"}) effects of various concentrations (i.e., 10--1000 µM) of Andrographolide on functional activity of NHE1/V-ATPase of the pH~i~ regulating mechanism in cultured human cervical cancer cells. Andrographolide showed a concentration-dependent inhibition on NHE1/V-ATPase activity. Note that the dramatic inhibition on NHE1/V-ATPase activity upon acute Andrographolide treatment is around ≈80%, and that it reverses completely ([Figure 4](#cancers-12-00387-f004){ref-type="fig"}A) in cultured human cervical cancer cells, i.e., HeLa cells. Moreover, the Andrographolide-induced reduction on expression of NHE1 isoforms ([Figure 7](#cancers-12-00387-f007){ref-type="fig"}) was detected when the concentration was higher than 30 µM, either upon 24 and 48 h Andrographolide treatment. Indeed, recent studies show that Andrographolide inhibited the proliferation of cancer cells with GI~50~ values (the concentration required to inhibit the 50% growth) ranging from 10 to 28 μM on diverse cancer cell lines for different types of human cancers, including breast, CNS, color, lung, melanoma, ovarian, prostate, and renal \[[@B29-cancers-12-00387]\]. Similarly, our present study shows that Andrographolide (10--1000 µM) concentration-dependently decreased cellular viability ([Figure 5](#cancers-12-00387-f005){ref-type="fig"}A--D) and migration ([Figure 6](#cancers-12-00387-f006){ref-type="fig"}), either upon the 24 or 48 h Andrographolide treatment in human cervical cancer cells. Note that the Andrographolide-induced inhibition on cellular viability was significantly observed when the concentration was higher than 100 or 300 μM, either upon 24 and 48 h Andrographolide treatment, respectively. In other words, our present results implicate that the Andrographolide-induced inhibition on NHE1 activity/expression does not only highly correlate with the inhibition on viability and migration, but also more specific/sensitive to human cervical cancer cells than human normal cervical cells ([Figure 5](#cancers-12-00387-f005){ref-type="fig"}, [Figure 6](#cancers-12-00387-f006){ref-type="fig"} and [Figure 7](#cancers-12-00387-f007){ref-type="fig"}). Therefore, Andrographolide can be used in clinics to treat cervical cancer by inhibition cell viability without affecting the viability of normal cervical cells in the concentration range of 10--100 μM. Such differentiation of GI 50 concentration of Andrographolide between cancer cells and normal cells not only provides efficient therapy for killing cervical cancer cells, but also prevents the possible side effect of harming normal cervical cells. However, more specific cellular/molecular underlying mechanisms for this await further investigation. Moreover, it is notable that after 24--48 h the cells will be in the plateau phase instead of the logarithmic growth phase, which will affect proliferation and viability. It is clearly visible ([Figure 5](#cancers-12-00387-f005){ref-type="fig"}A,B) that cells after 24 and 48 h reached 100% of confluence in controls. Therefore, our present study might "underestimate" the effect of a drug (Andrographolide). Additionally, whether the cell proliferation assays are carried out on cells that are constantly proliferating is an important factor to rule out possible artefacts. On the other hand, as Andrographolide showed a significant effect on cell growth ([Figure 5](#cancers-12-00387-f005){ref-type="fig"}), therefore, the observed inhibitory effect on migration, as shown in [Figure 6](#cancers-12-00387-f006){ref-type="fig"}, might be affected, more or less, by the die off of cells. Therefore, a further experiment on migration only awaits to be performed.

Apoptosis, a programmed cell death, is activated by the cell itself through the death receptor activation (extrinsic) and stress-inducing stimuli (intrinsic) pathways to Caspase activation \[[@B58-cancers-12-00387]\]. Expression of apoptotic regulatory proteins, including both anti-apoptotic Bcl-2 and pro-apoptotic members Bax \[[@B39-cancers-12-00387]\] was analyzed after the pretreatment with Andrographolide for 24--48 h to see the possible apoptosis effect. In the present study, we found that chronic exposure to higher concentrations of Andrographolide ([\>]{.ul} 30 μM for 24 and 48 h) significantly activated apoptotic cascade, i.e., decreasing of pro Caspase 3, Bcl-2, PARP, while increasing cleaved PARP and cleaved Caspase 3 ([Figure 7](#cancers-12-00387-f007){ref-type="fig"}). Moreover, the Bcl-2 in the mitochondria determines the mitochondrial release of apoptosis-associated factors such as apoptosis-protease activated factor 1, apoptosis-inducing factor, and cytochrome c \[[@B59-cancers-12-00387]\]. Our present study showed that the 100 μM Andrographolide induced a reduction on Bcl-2 ([Figure 7](#cancers-12-00387-f007){ref-type="fig"}) which represents the ability of Andrographolide on abolishing the mitochondrial membrane potential. Meanwhile, the uneven protein level of β-actin, i.e., β-actin, decreased in a concentration-dependent manner (from left to right), in some of our [supplementary data](#app1-cancers-12-00387){ref-type="app"}. Though it reflected a possible incorrect technique on the part of the researcher, in light of "β-actin" being the internal control of that line, therefore, we nonetheless took it to be reliable data. This was especially so when we noticed the interesting and encouraging result that although the actin decreased in a concentration-dependent manner after Andrographolide treatment, the cleaved PARP protein levels increased in a concentration-dependent manner after Andrographolide treatment. Therefore, this assures us that the increase effect of cleaved PARP was valid. Note that the Andrographolide-induced inhibition on protein expression of NHE1 was time- and concentration-dependently correlated with that of Andrographolide-induced change on apoptotic cascade ([Figure 7](#cancers-12-00387-f007){ref-type="fig"}A). As an acidic pH condition induces growth arrest or cell death \[[@B60-cancers-12-00387]\], inhibition on NHE activity/expression may play a significant role in the progression of apoptosis. Indeed, p90rsk, hyperactive NHE1, even at the resting pH and the resulting cellular alkalinization, was reported to be directly related to uncontrolled proliferation in malignant cells \[[@B23-cancers-12-00387]\]. Thus, p90rsk that regulates cellular proliferation, as well as NHE1, may be an important molecule for therapeutic targeting in Andrographolide-induced inhibition on cancer progression. The underlying molecular mechanism awaits further experiments. Moreover, the concept of alkaline pH levels in tumor cells is a new phenomenon that needs to be further investigated and explained in the future study. Moreover, similar experiments on apoptotic proteins in normal cervical cell lines, i.e., End1 and Ect1, are helpful for translational application in clinics. In addition, as Andrographolide has many effects, the effect of cariporide and bafilomycin on cell proliferation/migration/proteins expression and how it compares to the effect of Andrographolide awaits further investigation in the future. All things considered, our present study suggests that Andrographolide is a promising novel agent in the treatment of cervical cancer in clinics.

4. Materials and Methods {#sec4-cancers-12-00387}
========================

4.1. Cell Culture {#sec4dot1-cancers-12-00387}
-----------------

Human cervical cancer cells (HeLa-cells) were a kind gift provided from Professor Y.W. Lin, Department of Microbiology and Immunology, Taipei, Taiwan. The human normal endocervical cells (End1-cells/E6E7, CRL-2615^®^) and human normal ectocervical cells (Ect1-cells/E6E7, CRL-2614^®^) were bought commercially from American Type Culture Collection (ATCC^®^, Manassas, VA, USA). HeLa cells were cultured in 90% Dulbecco's Modified Eagle Medium (pH~o~ = 7.4) with high glucose (25 mM) containing 17.9 mM NaHCO~3~, 10% FBS (fetal bovine serum), 1% non-essential amino acids, 1% sodium pyruvate, and 1% antibiotic antimycotic solution (100 units/mL penicillin, 10 mg/mL streptomycin sulfate, and 0.025 mg/mL amphotericin-B). End1 and Ect1 cells were cultured in Defined Keratinocyte-SFM (10744-019, Gibco^TM,^ San Jose, CA USA) containing 1% antibiotic antimycotic solution. All cells were cultured at 37 °C/5% CO~2~, pH~o~ = 7.4, and the culture media was renewed every 2--3 days. When the cells reached 70--80% in growth density, they were routinely subcultured and further experiments were conducted.

4.2. Microspectrofluorometry and In Situ Calibration of Intracellular pH Fluorescent Dye BCECF {#sec4dot2-cancers-12-00387}
----------------------------------------------------------------------------------------------

To measure pH~i~ and functional characterization of pH~i~ regulating mechanism, cells were detected by microspectrofluorometry. This procedure has been described in detail in our previous reports \[[@B50-cancers-12-00387],[@B53-cancers-12-00387],[@B61-cancers-12-00387]\]. Cells were loaded for with 3 μM BCECF-AM (2′,7′-bis(2-carboxethyl)-5(6)-carboxy-fluorescein--acetoxymethyl, Thermo Fisher, Waltham, MA). BCECF epifluorescence was collected at 530nm with a converted inverted microscope, with alternative and repetitive excitation of the BCECF fluorophore at 490 and 440 nm under mono chromator control (Cairn Research, Kent, UK). Signals were digitized using a CED digitizer, and the fluorescence emission ratios were calculated and converted to pH~i~ values by dividing the F490 by the F440 emission. BCECF fluorescence ratio was calibrated using the high-\[K^+^\] nigericin technique (see section below for more details). Intracellular acidification was induced by transiently superfusing cells with 20 mM NH~4~Cl, a procedure known as NH~4~Cl prepulse that is shown in the section above. Measurement of pH~i~ and recovery rates typically commenced 1min after NH~4~Cl, and pH recovery rates were calculated from the change in pH~i~ over a 0.5-min time period (dpH~i~/dt). Note that the ammonium chloride was added to solution without osmotic compensation (see [Section 3](#sec3-cancers-12-00387){ref-type="sec"} for more details).

The result of in situ calibration curve by using microspectrofluorometry technique with nigericin (10 µM) in Hela cells, End1 cells, and Ect1 cells is shown in [supplementary figures: Figures S1--S3](#app1-cancers-12-00387){ref-type="app"}, respectively. Note that nigericin acted as a potassium ionophore to equalize the pH~i~ to the pH~e~. The nigericin calibration solution. Please see the section below for details.

4.3. NH~4~Cl Prepulse Technique {#sec4dot3-cancers-12-00387}
-------------------------------

NH~4~Cl prepulse techniques were used to induce acute intracellular acid loading, and the procedure has been described in detail in our previous reports \[[@B50-cancers-12-00387],[@B52-cancers-12-00387],[@B62-cancers-12-00387]\]. This method can be explained by four phases as shown in the farthest left part of [Figure 1](#cancers-12-00387-f001){ref-type="fig"}C: phase 1 (rapid alkalization), phase 2 (slow recovery), phase 3 (rapid acidification), and phase 4 (pH~i~ regulation). Thus, the acid extruder activity was measured as the slope of recovery from NH~4~Cl (20 mM) induced intracellular acidification. Throughout the whole experiment, the change of pH~i~ induced by the tested drug/designed condition was compared around the 1st min after treating the drug/designed condition, unless otherwise stated, and pH recovery rates were calculated from the change in pH~i~ over a 0.5-min time period (dpH~i~/dt). The background fluorescence and auto-fluorescence were small (\<5%) and were ignored.

4.4. Chemicals and Solutions {#sec4dot4-cancers-12-00387}
----------------------------

Standard HEPES-buffered Tyrode solution (air equilibrated) was composed of (in mM): 140 NaCl, 4.5 KCl, 1 MgCl~2~, 2.5 CaCl~2~, 11 glucose, 20 HEPES. In Na^+^ free HEPES solution, 140 NaCl were replaced with 140 NMDG (N-methyl-D-glucamine).

Nigericin Calibration Solution containing (mM): KCl 140, MgCl2 1, and Nigericin 0.01, was buffered with one of the following organic buffers: 20mM MES (pH 5.5 and 6.5), 20 mM HEPES (pH 7.0, 7.5, and 8.5), or 20 mM CAPSO (pH 9.5), and was adjusted to the correct pH with 1 M NaOH at 37 °C (Sigma, Dorset, UK).

In the NH~4~Cl prepulse solution, NH~4~Cl was added directly to the solution without osmotic compensation. All different solutions were adjusted to 7.4 with 4N NaOH, 4N HCl, and KOH, respectively, at 37 °C.

HOE 694 (3-methylsulphonyl-4-piperidinobenzoyl, guanidine hydrochloride, Sanofi-Aventis, Paris, France), Bafilomycin A1 (LC Laboratories, Woburn, MA, USA), DIDS (4,4′-Diisothiocyanatostilbene-2,2′-disulfonic acid, Sigma-Aldrich, St. Louis, MO, USA), were added to the solutions at the indicated concentrations shortly prior to use. All other chemicals were purchased from Sigma (Dorset, UK) and Merck (Dorset, UK).

4.5. MTT (3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium Bromide) Assay {#sec4dot5-cancers-12-00387}
-----------------------------------------------------------------------------

MTT assay was used to detect the cell viability of HeLa cells, End1 cells, and Ect1 cells after being incubated with Andrographolide for the designated times. Briefly, cells (≈1 × 10^5^ or ≈3 × 10^5^) were seeded in 96-well plates and allowed to attach overnight. Culturing media with various concentrations of Andrographolide were administrated to a final volume of 200 μL. After treatment for 24 or 48 h, the cells were incubated at 37 °C with 20 μL of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution (5 mg/mL, Abcam, Cambridge, UK) for 4 h. The MTT formazan crystals were dissolved in 150 μL Dimethyl Sulfoxide (Sigma), and a microplate reader (Tecan, Mannedorf, Switzerland) was used to measure colorimetric absorbance at 562 nm.

4.6. Wound Healing Assay {#sec4dot6-cancers-12-00387}
------------------------

In order to rule out technical problems caused by the pipet-scratching in the in vitro wound healing test, we used an ibidi culture-insert 2 well (Cat. No: 81176, ibidi) in the present study, due to its defined size of the cell-free gap (500 μm). We plated the ibidi culture-insert 2 well on the 6-well culture plate, and then seeded cells into the ibidi culture-insert 2 well. When the cells reached 100% confluence, we removed the ibidi culture-insert 2 well to create a cell-free gap and then exposed cells to the fresh serum-free DMEM (Dulbecco's Modified Eagle Medium) medium both with and without andrographolide for 48 h (for detailed experimental procedures, please refer to the manufacturer's instructions). We imaged the live cells immediately (0 h) after creation of the gap and monitored the gap's distance at 24 and 48 h. The cells migrating ability following the application of andrographolide was presented by normalizing the distance of the gap in each group to the control plus DMSO (dimethyl sulfoxide) group (C + D).

4.7. Western Blotting {#sec4dot7-cancers-12-00387}
---------------------

The procedure of immunoblotting analysis has been described in detail in our previous reports \[[@B50-cancers-12-00387]\]. In brief, for SDS-PAGE (sodium dodecyl sulfate--polyacrylamide gel electrophoresis) electrophoresis, denatured proteins were homogenized in a sample buffer (Bio-Rad, Hercules, CA, USA), fractionated on FastCast gels (Bio-Rad, Hercules, CA, USA) of either 7.5%, 10%, or 12%, depending on the molecular weight of the proteins of interest. Fractionated proteins were wet-transferred to PVDF (polyvinylidene difluoride) membranes (0.2 μm, GE Healthcare, Pittsburgh, PA, USA), blocked in 5% BSA (Bovine serum albumin) (Bioshop, Burlington, ON, Canada), and probed with primary antibodies (as listed above at the stated dilutions) overnight at 4 °C.

The primary antibodies used in the present study include anti-NHE1 (1:1000, TA328914, Origene; Rockville, MD, USA), anti-V-ATPase C1 monoclonal antibody (1:1000, sc-166848, Santa Cruz Biotechnology, Dallas, TX, USA), anti-β-actin (1:5000, GTX100118, GeneTex, Irvine, CA, USA), anti-pro Caspase 3 polyclonal antibody (1:1000, 9662, Cell Signaling), anti-cleaved Caspase 3 monoclonal antibody (1:500, 9664, Cell Signaling, Danvers, MA, USA), anti-Bcl-2 monoclonal antibody (1:1000, 15071, Cell Signaling), anti-pro and cleaved form PARP monoclonal antibody (1:1000, \#9532, Cell Signaling).

After being treated overnight, membranes were washed three times in TBST (Sodium Chloride, Trizma Base, 0.1% Tween-20, all from Sigma), and incubated with HRP-conjugated secondary goat anti-rabbit (1:2000, Cell Signaling Technology), or HRP-conjugated secondary horse anti-mouse (1:2000, Cell Signaling Technology) antibodies. Following secondary antibody incubation, the membranes were further washed three times in TBST, and incubated with enhanced chemiluminescence substrate (Bio-Rad, Hercules, CA, USA). Western blot images were obtained on a UVP BioSpectrum 500 imager (UVP, Upland, CA, USA). Equal loadings were confirmed by probing with anti-β-actin antibody. Protein expression levels were quantified by using ImageJ software analysis.

4.8. Statistical Analysis {#sec4dot8-cancers-12-00387}
-------------------------

Statistical analysis was performed using Student's *t*-test and one-way ANOVA followed by Tukey's posttest. Data were analyzed using Prism (GraphPad Software, La Jolla, CA, USA), and the level of significance was set at \* *p* \< 0.05 and \*\* *p* \< 0.005 versus the control. All data are expressed as means ± standard error of the mean (SEM).

5. Conclusions {#sec5-cancers-12-00387}
==============

In the present study, we have, for the first time, provide straightforward, functional, and molecular evidence of the coexistence of Na^+^-dependent acid-extruders, i.e., NHE1 and vacuolar proton pump (V-ATPase), for acid-extruding mechanism in cultured human cervical cancer cells, i.e., Hela cells. Moreover, Andrographolide regulates apoptotic proteins to induce cells apoptosis, and concentration-dependently decreases pH~i~ by decreasing activity of NHE1/V-ATPase and expression of NHE1 in Hela cells. Thus, Andrographolide implicates a promising novel agent in the treatment of cervical cancer in clinics.

The following are available online at <https://www.mdpi.com/2072-6694/12/2/387/s1>, Figure S1. In situ calibration of intracellular pH in cultured human cervical cancer cells (HeLa), Figure S2: In situ calibration of intracellular pH in cultured human cervical normal cells (End1), Figure S3: In situ calibration of intracellular pH in cultured human cervical normal cells (Ect1), Figure S4: Western Blot data replication for NHE1, Pro-caspase 3, Bcl-2 and β-actin, Figure S5: Western Blot data replication for NHE1, PARP, cleaved-PARP, Bcl-2 and β-actin, Figure S6: Western Blot data replication for PARP, cleaved-PARP, Pro-caspase 3 and β-actin.
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![The resting intracellular pH (pH~i~) and kinetic steady-state pH~i~ in the endocervical cells (End1), ectocervical cells (Ect1), and human cervical cancer cells (HeLa) cells. (**A**--**C**) The top bars show the buffer system used in perfusion experiments. The periods of application of NH~4~Cl prepulse are shown with bars above the trace. The blue and red dotted lines represent the original and the new steady-state pH~i~, following NH~4~Cl prepulse induced intracellular acidification, respectively. Note that the numbers 1--4 shown in the farthest left trace of represented the typical four phases of NH~4~Cl prepulse (see more details in [Section 4](#sec4-cancers-12-00387){ref-type="sec"}). The trace **A**--**C** represented the typical trace derived in experiments on End1 cells, Ect1 cells, and HeLa cells, respectively.](cancers-12-00387-g001){#cancers-12-00387-f001}

![Effect of Na^+^-free solution on intracellular pH (pH~i~) recovery subsequent induced intracellular acidification in HEPES-buffered condition in the End1, Ect1, and HeLa cells. (**A**--**C**) The top bars show the buffer system used, and the bars above or below the trace show the application of NH~4~Cl and treatment, respectively. (**D**--**F**) Histograms show the pH~i~ recovery slope (%) following induced intracellular acidification averaged for six experiments similar to those shown in **A**--**C**, respectively. The pH~i~ recovery rate was measured at pH~i~ = 6.96 ± 0.08, the level of significance was set at \*\* *p* \< 0.005 versus the control. Error bars represent the mean ± SEM (standard error mean).](cancers-12-00387-g002){#cancers-12-00387-f002}

![Effect of Na^+^-free solution, HOE 694, Na^+^-free solution plus bafilomycin A1 (Balifo), and HOE 694 plus bafilomycin A1 (Balifo) on intracellular pH (pH~i~) recovery subsequently induced intracellular acidification in HEPES-buffered condition. (**A**--**D**) The top headings show the cells used, and the bars above or below the trace show the application of NH~4~Cl and treatment. The first part of trace **A**--**D** shows a typical pH~i~ recovery from an induced intracellular acidification in HEPES-buffered solution as control. The other part shows the pH~i~ recovery slope after application of different design conditions, i.e., Na^+^ free, HOE 694, Na^+^-free solution plus bafilomycin A1 (Balifo), and HOE 694 plus bafilomycin A1 (Balifo), respectively. (**E**--**H**) Histogram shows the normalization of pH~i~ recovery rate of acid extrusion that are averaged for 5--6 experiments similar to those shown in **A**--**D**, respectively. The pH~i~ recovery rate measured is shown at the top of the histogram, and \*\* *p* \< 0.005 versus the control. Error bars represent the mean ± SEM (standard error mean).](cancers-12-00387-g003){#cancers-12-00387-f003}

![Effect of acute treatment with Andrographolide on intracellular pH (pH~i~) recovery rate in HEPES-buffered solution. (**A**,**C**) The top bar shows the buffer system used, and the bars above and below the trace show the period of acute application of NH~4~Cl and Andrographolide (10--1000 µM), respectively. The most left and right traces show the typical NH~4~Cl prepulse technique as a control and wash, respectively. (**B**) Histograms show the normalization of change on pH~i~ recovery rate after acute application of Andrographolide (10--1000 µM) in HEPES-buffered condition, respectively. The pH~i~ recovery rate measured is shown at the top of the histogram, and \* *p* \< 0.05 and \*\* *p* \< 0.005 versus the control. Error bars represent the mean ± SEM (standard error mean).](cancers-12-00387-g004){#cancers-12-00387-f004}

![Effect of chronic treatment of Andrographolide (3--300 µM) on cell viability in HeLa cells, End1 cells, and Ect1 cells. (**A**,**B**) The notes at the bottom of cells show the condition of cell viability in experiments, and the bars at the right bottom of the cells show the scale of the length of picture (50 μm). The top left picture of A and B shows a typical picture of cell viability under normal culture medium with the solvent of DMSO (Dimethyl sulfoxide) (0.1%) as control for 24 and 48 h, respectively. The other picture of A and B shows a picture of cell viability after chronic treatment of Andrographolide in different concentrations, i.e., 10, 30, 50, 100, and 300 µM, in HeLa cells for 24 and 48 h, respectively. (**C**,**D**) The concentration response curves show the normalization of cell viability of various concentrations of Andrographolide in HeLa cells, End1 cells, and Ect1 cells that averaged in several experiments similar to that shown in A,B. The \*\* *p* \< 0.005 versus the control. Error bars represent the mean ± SEM (standard error mean).](cancers-12-00387-g005){#cancers-12-00387-f005}

![The concentration effect of chronic treatment of Andrographolide (3--300 µM) on wound migration in HeLa cells. (**A**) The words on top of the pictures show the chronic application of various concentrations of Andrographolide and DMSO (Dimethyl sulfoxide) used. The pictures in the first, second, and third panels show the time (0, 24, and 48 h, respectively) after the ibidi culture-insert 2 well was removed. The effect of adding 50, 100, and 300 μM Andrographolide on cell migration for 48 h at the third row, i.e., after removing the ibidi culture-insert 2 well for 48 h, was enlarged directly and shown in the right bottom of [Figure 6](#cancers-12-00387-f006){ref-type="fig"}**A** (the fourth row). The bars at the right bottom of the cells show the scale of the length of picture (500 μm). (**B**,**C**) Histograms show the average normalization of wound migration in 11 experiments similar to that shown in **A**. The \* *p* \< 0.05 and \*\* *p* \< 0.005 versus the control, respectively. Error bars represent the mean ± SEM (standard error mean).](cancers-12-00387-g006){#cancers-12-00387-f006}

![Effect of chronic treatment of Andrographolide (Andro; 10--100 µM) (24 and 48 h) on the expression of Na^+^/H^+^ exchanger isoform 1 (NHE1) and apoptotic proteins in HeLa cells. (**A**). The Western blot results show the changes of isoforms of poly-ADP-ribose-polymerase (PARP), Cleaved PARP, pro Caspase 3, cleaved Caspase 3, Bcl-2, and β-Actin expression (marked at the farthest left) after 24 and 48 h treatment with Andrographolide (10--100 µM; marked at the top) in the HeLa cells. Note that the expression of each band is shown right under or above the blot; the predicted size of protein marker is shown at the right of the blot; the size of the detected protein is shown at the left of the blot. (**B**--**E**) The histograms show the relative expression ratio of Cleaved PARP and PARP, the ratio of cleaved Caspase 3 and Caspase 3, NHE1 and Bcl-2 to β-Actin that were averaged for several experiments similar to those shown in **A**, respectively. The \* *p* \< 0.05 and \*\* *p* \< 0.005 versus the control, respectively. Error bars represent the mean ± SEM (standard error mean).](cancers-12-00387-g007){#cancers-12-00387-f007}
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